Abstract

The placental multidrug transporters, P‐glycoprotein (P‐gp, encoded by ABCB1) and breast cancer resistance protein (BCRP,ABCG2) protect the foetus from exposure to maternally derived glucocorticoids, toxins and xenobiotics. During pregnancy, maternal glucocorticoid levels can be elevated by stress or exogenous administration. We hypothesized that glucocorticoids modulate the expression of ABCB1/P‐gp and ABCG2/BCRP in the first trimester human placenta. Our objective was to examine whether dexamethasone (DEX) or cortisol modulate first trimester placental expression of multidrug transporters and determine whether cytotrophoblasts or the syncytiotrophoblast are/is responsible for mediating these effects. Three models were examined: (i) an ex‐vivo model of placental villous explants (7‐10 weeks), (ii) a model of isolated first trimester syncytiotrophoblast and cytotrophoblast cells and (iii) the BeWo immortalized trophoblast cell line model. These cells/tissues were treated with DEX or cortisol for 24 hour to 72 hour. In first trimester placental explants, DEX (48 hour) increased ABCB1 (P < .001) and ABCG2 (P < .05) mRNA levels, whereas cortisol (48 hour) only increased ABCB1 mRNA levels (P < .01). Dexamethasone (P < .05) and cortisol (P < .01) increased BCRP but did not affect P‐gp protein levels. Breast cancer resistance protein expression was primarily confined to syncytiotrophoblasts. BeWo cells, when syncytialized with forskolin, increased expression of BCRP protein, and this was further augmented by DEX (P < .05). Our data suggest that the protective barrier provided by BCRP increases as cytotrophoblasts fuse to form the syncytiotrophoblast. Increase in glucocorticoid levels during the first trimester may reduce embryo/foetal exposure to clinically relevant BCRP substrates, because of an increase in placental BCRP.

Highlights

  • The placenta supplies nutrition to the growing foetus while simultaneously forming a barrier which protects the foetus from exposure to hormones, drugs and toxins present in the maternal circulation.[1,2,3] This barrier function is supported by the ABC family of efflux transporters.[4]

  • This study is the first to show that glucocorticoids increase the expression of ABCB1 mRNA, ABCG2 mRNA and breast cancer related protein (BCRP) protein in the first trimester human placenta

  • We demonstrated that BCRP is most highly expressed in the syncytiotrophoblast cells and that BCRP is up-regulated following syncytialization of trophoblast cells

Read more

Summary

| INTRODUCTION

The placenta supplies nutrition to the growing foetus while simultaneously forming a barrier which protects the foetus from exposure to hormones, drugs and toxins (including glucocorticoids, organophosphate pesticides and endocrine disruptors) present in the maternal circulation.[1,2,3] This barrier function is supported by the ABC family of efflux transporters.[4] In this regard, the multidrug resistance transporters, P-glycoprotein (P-gp; encoded by the ABCB1 gene) and breast cancer resistance protein (BCRP [breast cancer resistance protein]; encoded by the ABCG2 gene) are primarily localized to the apical membrane of the syncytiotrophoblast They efflux substrates from within the syncytiotrophoblast back into the maternal circulation preventing factors present in the maternal blood from entering the foetal compartment.[3]. We determined how trophoblast fusion into syncytium modifies transporter expression and if this is affected by subsequent glucocorticoid exposure

| MATERIALS AND METHODS
| RESULTS
Findings
| DISCUSSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.